Home / News (page 3)

News

Hanover Insurance Group, Inc. (NYSE: THG): The Hanover Enhances Education Advantage Product Suite;

As a leading provider of insurance protection for educational institutions, The Hanover Insurance Group, Inc. (NYSE: THG) recently declared it has expanded its Hanover Education Advantage product suite to include improved and broadened coverages, providing its agent partners with more opportunities to tailor insurance protection to the needs of their …

Read More »

Morningstar Assigns New Ratings to 83 U.S. Funds; Downgrades Four Funds; Affirms Ratings on 74 Funds, One Target-Date Series in June: Morningstar, Inc. (NASDAQ: MORN)

Morningstar, Inc. (NASDAQ: MORN), a leading provider of independent investment research, has published a summary of Morningstar Analyst Rating™ activity for 161 U.S. mutual funds and exchange-traded funds (ETFs) and two target-date series that occurred in June 2017. The Morningstar Analyst Rating for funds represents Morningstar’s conviction in the fund’s …

Read More »

Nielsen and Tennis Channel Extend Agreement to Include National TV Ratings:

Recently, Nielsen (NYSE: NLSN) and Tennis Channel declared that they have expanded their relationship, beyond the Nielsen Local TV Ratings Service, to also include Nielsen’s National TV Ratings service. Tennis Channel is the only 24-hour, television-based multimedia destination dedicated to both professional tennis and its lifestyle. This multi-year agreement provides …

Read More »

Healthcare News updates: Valeant Pharmaceuticals International, Inc.’s (NYSE: VRX and TSX: VRX)

Valeant Pharmaceuticals International, Inc.’s (NYSE: VRX and TSX: VRX) wholly owned partner, Bausch + Lomb, a leading global eye health company, recently declared the introduction of Bausch + Lomb AQUALOX® contact lenses, the first new innovation in the bi-weekly contact lens category in half a decade, to the Japanese market. …

Read More »

Healthcare Stocks Buzz; Titan Pharmaceuticals, Inc. (NASDAQ: TTNP)

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a specialty pharmaceutical company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura™ long-term, continuous drug delivery technology, declared recently that it has reached a Cooperative Research and Development Agreement (CRADA) with Walter Reed Army Institute of Research (WRAIR) and Southwest …

Read More »

Stocks Buzz: Trovagene, Inc. (NASDAQ: TROV)

Trovagene, Inc. (NASDAQ: TROV), a precision medicine biotechnology company, declared recently that is has formally engaged PRA Health Sciences, a leading, global contract research organization (CRO), to conduct Trovagene’s Phase 1b/2 clinical trial of PCM-075, a polo-like kinase 1 (PLK1) inhibitor, in patients with acute myeloid leukemia (AML). Trovagene filed …

Read More »

Healthcare News Buzz: Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX)

Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, recently declared the appointment of Charles A. Rowland Jr. to its board of directors. With more than 30 years of biopharmaceutical industry experience, Mr. Rowland provides Viking with …

Read More »

Healthcare News Updates: IsoRay, Inc. (NYSE MKT: ISR)

IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head and neck and gynecological cancers, recently declared that it has received a response from the FDA regarding the Company’s pending 510(k) application for the …

Read More »

News in Focus: Eli Lilly and Company (NYSE: LLY)

Eli Lilly and Company (NYSE: LLY) and Purdue University recently declared a planned partnershipto conduct life science research. The five-year agreement, where Lilly will provide up to $52 million, marks Purdue’s leading planned partnershipwith a single company. “Purdue has enjoyed a long history of engagement with Lilly. Now Lilly and …

Read More »

News Alert: Egalet Corporation (Nasdaq: EGLT)

Egalet Corporation (Nasdaq: EGLT) (“Egalet” or the “Company”), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions, recently declared the pricing of its underwritten public offering of 16,666,667 shares of its common stock and accompanying warrants to purchase up to …

Read More »